---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-23-000004"
form_type: "8-K"
ticker: "CNSP"
cik: "0001729427"
company_name: "CNS Pharmaceuticals, Inc."
filed_at: "2023-01-03T23:59:59+00:00"
generated_at: "2026-06-20T20:57:18.467399+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# CNS Pharmaceuticals appoints Faith Charles as independent Chair of Board

## Summary
- Faith L. Charles appointed independent Chair of Board effective Dec 30, 2022.
- Compensation: $30,000 annual retainer, plus 10-year option for 3,500 shares at $2.40, vesting monthly over 36 months.
- Charles is a partner at Thompson Hine, leading its Life Sciences practice with over 30 years of experience.
- She also serves on boards of Avenue Therapeutics and Abeona Therapeutics.

## SEC filing metadata
- accession: 0001683168-23-000004
- form_type: 8-K
- ticker: CNSP
- cik: 0001729427
- company_name: CNS Pharmaceuticals, Inc.
- filed_at: 2023-01-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1729427/000168316823000004/0001683168-23-000004-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1729427/000168316823000004/cns_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-23-000004
- JSON: https://secwatch.observer/filing/0001683168-23-000004.json
- Plain text: https://secwatch.observer/filing/0001683168-23-000004.txt

## Key facts
- Executive change
  Faith Charles was appointed as Chairperson of the Board of Directors at CNS Pharmaceuticals, Inc..
  - Action: appointed
  - Role: Chairperson of the Board of Directors
  source text: On December 30, 2022, the Board of Directors of CNS Pharmaceuticals, Inc. (the “Company”) appointed Faith Charles as an independent member of the Company’s Board of Directors and as Chairperson of the Board of Directors, effective on such date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1729427/000168316823000004/0001683168-23-000004-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.